Hotline 24/7: 0909384389

Share links:

AATS 2022: Concurrent tricuspid valve surgery and LVAD implantation do not lower the incidence of right heart failure

Ngày 01/06/2022 06:34 | Lượt xem: 510

Concurrent tricuspid valve surgery and left ventricular assist device (LVAD)  implantation did not lead to a lower incidence of right heart failure (RHF) when compared to LVAD implantation alone in these select patients.

This was the conclusion of the TVVAD trial, findings of which were presented at the American Association for Thoracic Surgery (AATS) annual meeting (AATS 2022, 14–17 May, Boston, USA).

RHF continues to be a major source of morbidity and mortality following LVAD implantation, authors of the study note. Tricuspid regurgitation (TR) is frequently observed preoperatively in patients undergoing LVAD implantation; and the presence of moderate or severe TR prior to LVAD appears to be associated with a high incidence of RHF during the first six months after the procedure.

Several retrospective studies have evaluated whether concurrent surgical correction of the tricuspid valve at the time of LVAD implantation can reduce post-operative RHF and improve outcomes. Most of these studies did not demonstrate a significant benefit for concomitant tricuspid surgery; however, these analyses are inherently limited by selection bias.

“We felt that this question had not been definitively answered, so we decided to perform a randomised controlled study on this topic,” said presenter Yuting Chiang (New York Presbyterian/Columbia University Medical Center, New York, USA).

The purpose of the TVVAD trial was to determine the utility of tricuspid valve repair at the time of LVAD implantation for patients who present with moderate or severe TR. This study evaluated whether concurrent surgical correction of moderate or greater TR in patients undergoing LVAD implantation prevents post-operative RHF compared to LVAD implantation alone. Chiang commented: “We used an adaptive trial design with a planned interim analysis to allow for early stopping of the trial for efficacy or futility and to allow for sample size re-estimation.”

Sixty patients with moderate or severe TR on preoperative echocardiography were randomised to either LVAD implantation alone (No TVR, n=28) or LVAD implantation with concomitant tricuspid valve surgery (TVR, n=32).  Randomisation was stratified by pre-operative right ventricular (RV) dysfunction (none/mild vs moderate vs severe).

There was no significant difference in the primary outcome of the two arms. At six months, 46.43% of the TVR group and 43.75% of the No TVR group had experienced moderate to severe RHF. The study also looked at the incidence of all-cause mortality, atrioventricular block, major bleeding, prolonged mechanical ventilation, and stroke and found no statistically significant difference. Based on this analysis, the trial has been discontinued for futility. Chiang said that they plan to follow-up with these patients and perform another analysis at one year to evaluate whether there are long-term benefits.

Muath Bishawi (Duke University, Durham, USA), co-principal investigator for the trial, added: “In our study, we focused on the primary endpoint, which was right heart dysfunction up to six months.  Many other endpoints in the study, however, may be of interest to focus on for future trials.  These may include late re-admissions beyond six months, quality-adjusted life years, and cost in hospital and long-term care.”

Source CardiovascularNews

Duc Tin CLinic

Tin tức liên quan

Enrolment reaches midway point in trial of Early Bird bleed monitoring system

Eight-fold increased risk of heart attack seen in patients with subclinical obstructive coronary atherosclerosis

ACC 2023: REVIVED-BCIS-2 results challenge “long-held beliefs” on myocardial viability testing prior to PCI

Blood pressure successfully cut in RADIANCE II ultrasound renal denervation trial

New data examine mortality rates and cardiac damage in early-stage aortic stenosis patients

SUPPORT CONSULTANT

CUSTOMER REVIEWS

• I am Nguyen Thanh Sang, born in 1990. Since the examination and treatment at the clinic Duc Tin, I am very grateful to the Doctor for explaining and sharing about my illness. During the treatment time in the clinic I was very caring staff of the clinic. Now my illness has improved in a good way. Expect more and more clinic to be able to save many patients.

  I sincerely thank you !. Tel: 0938303275

• Huynh Thi Muoi, born in 1940, was examined and treated at Duc Tin Clinic. I am very pleased about how to serve and care patients of the clinic. The doctor is committed to explaining and sharing with the patient.

  Huynh Thi Muoi sincerely thank you! Phone number: 0972868746

• As I said Duc Tin surgical clinin is where my family trust, hope to visit. Physicians caring, thoughtful, gentle to the patient. Nurses and staff clinic polite, cheerful and thoughtful. This clinic clean, sterile, so I would love to. Tel: +84949914060.

• The doctor is very caring, attentive and very gentle nurse, courteous, affable with me. The clinic is clean, comfortable, polite. I enjoyed this faith. Every visit I was very relieved disease. Tel: 0839820792.

• I was patient, had to clinics of Dr. Le Duc Tin. I see very conscientious doctor patient care, answer any questions and very dedicated staff from the receptionist to the children tested, nursing. Clinics very clean and spacious. I'm very satisfied. Tel: +841227880829.

Search

News

Customer support